How Effective Is Neoadjuvant Therapy Followed by Surgery for Pathologic Single-Station N2 Non-Small Cell Lung Cancer?

OBJECTIVE: The optimal treatment strategy for pathologic single-station N2 (pN2a1) non-small cell lung cancer (NSCLC)—surgery first followed by adjuvant treatment (SF) or neoadjuvant therapy followed by surgery (NS)—remains unclear. We compared disease-free survival (DFS) and overall survival (OS) a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Semin Thorac Cardiovasc Surg
Hauptverfasser: Keshava, Hari B., Tan, Kay See, Dycoco, Joseph, Livschitz, Jennifer, Bott, Matthew J., Huang, James, Rusch, Valerie W., Isbell, James M., Molena, Daniela, Bains, Manjit S., Jones, David R., Rocco, Gaetano
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904958/
https://ncbi.nlm.nih.gov/pubmed/32853736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.semtcvs.2020.08.006
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge